Theophylline in asthma

New England Journal of Medicine

Volumn 334, Issue 21, 1996, Pages 1380-1388

  Weinberger, Miles ^a,c   Hendeles, Leslie ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALLOPURINOL; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CIMETIDINE; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DISULFIRAM; ENOXACIN; ERYTHROMYCIN; ESTROGEN; FLUVOXAMINE; INTERFERON; METHOTREXATE; MEXILETINE; NEDOCROMIL; ORCIPRENALINE; PENTOXIFYLLINE; PROPAFENONE; PROPRANOLOL; SALBUTAMOL; SALMETEROL; TACRINE; TERBUTALINE; THEOPHYLLINE; TIABENDAZOLE; TICLOPIDINE; TROLEANDOMYCIN; UNINDEXED DRUG; VERAPAMIL; ZILEUTON;

ASTHMA; BRONCHODILATATION; DRUG EFFICACY; DRUG MECHANISM; HEADACHE; HUMAN; IMMUNOPHARMACOLOGY; IRRITABILITY; NAUSEA; PRIORITY JOURNAL; REVIEW; VOMITING;

ASTHMA; HUMANS; THEOPHYLLINE;

EID: 0029878681     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199605233342107     Document Type: Review

References (100)

1. Herrmann G, Aynesworth MB. Successful treatment of persistent extreme dyspnea "status asthmaticus": use of theophylline ethylene diamine (aminophylline, U.S.P.) intravenously. J Lab Clin Med 1937;23:135-48.
2. Brown EA. New type of medication to be used in bronchial asthma and other allergic conditions. N Engl J Med 1940:223:843-6.
3. Weinberger MM, Bronsky EA. Evaluation of oral bronchodilator therapy in asthmatic children: bronchodilators in asthmatic children. J Pediatr 1974;84:421-7.
4. Idem. Interaction of ephedrine and theophylline. Clin Pharmacol Ther 1975;17:585-92.
5. Jenne JW, Wyze MS, Rood FS, MacDonald FM. Pharmacokinetics of the-ophylline: application to adjustment of the clinical dose of aminophylline. Clin Pharmacol Ther 1972;13:349-60.
6. Ginchansky E, Weinberger M. Relationship of theophylline clearance to oral dosage in children with chronic asthma. J Pediatr 1977;91:655-60.
7. Weinberger M, Hendeles L, Bighley L. The relation of product formulation to absorption of oral theophylline. N Engl J Med 1978;299:852-7.
8. Hendeles L, Weinberger M, Johnson G, Monitoring serum theophylline levels. Clin Pharmacokinet 1978;3:294-312.
9. Barnes PJ, Pauwels RA, Theophylline in the management of asthma: time for reappraisal? Eur Respir J 1994;7:579-91.
10. Hambleton G, Weinberger M, Taylor J, et al. Comparison of cromoglycate (cromolyn) and theophylline in controlling symptoms of chronic asthma. Lancet 1977;1:381-5.
11. Nassif EG, Weinberger M, Thompson R, Huntley W, The value of maintenance theophylline in steroid-dependent asthma. N Engl J Med 1981; 304:71-5.
12. Dusdieker L, Green M, Smith GD, Ekwo EE, Weinberger M. Comparison of orally administered metaproterenol and theophylline in the control of chronic asthma. J Pediatr 1982;101:281-7.
13. Joad JP, Ahrens RC, Lindgren SD, Weinberger MM. Relative efficacy of maintenance therapy with theophylline, inhaled albuterol, and the combination for chronic asthma. J Allergy Clin Immunol 1987;79:78-85.
14. Brenner M, Berkowitz R, Marshall N, Strunk RC, Need for theophylline in severe steroid-requiring asthmatics. Clin Allergy 1988;18:143-50.
15. Rivington RN, Boulet LP, Cote J, et al. Efficacy of Uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids. Am J Respir Crit Care Med 1995;151:325-32.
16. Kidney J, Dominguez M, Taylor PM, Rose M, Chung KF, Barnes PJ. Immunomodulation by theophylline in asthma: demonstration by withdrawal of therapy. Am J Respir Crit Care Med 1995;151:1907-14.
17. Hendeles L, Harman E, Huang D, O'Brien R, Blake K, Delafuente J. The-ophylline attenuation of airway responses to allergen: comparison with cromolyn metered-dose inhaler. J Allergy Clin Immunol 1995;95:505-14.
18. Sullivan P, Bekir S, Jaffar Z, Page C, Jeffery P, Costello J. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 1994; 343:1006-8. [Erratum, Lancet 1994;343:1512.]
19. Magnussen H, Reuss G, Jorres R. Theophylline has a dose-related effect on the airway response to inhaled histamine and methacholine in asthmatics. Am Rev Respir Dis 1987;136:1163-7.
20. Koenig JQ, Dumler K, Rebolledo V, Williams PV, Pierson WE. Theophylline mitigates the bronchoconstriclor effects of sulfur dioxide in subjects with asthma. J Allergy Clin Immunol 1992;89:789-94.
21. Fabbri LM, Alessandri MV, De Marzo N, et al. Long-lasting protective effect of slow-release theophylline on asthma induced by ultrasonically nebulized distilled water. Ann Allergy 1986;56:171-6.
22. Pollock J, Kiechel F. Cooper D, Weinberger M. Relationship of serum the-ophylline concentration to inhibition of exercise-induced bronchospasm and comparison with cromolyn, Pediatrics 1977;60:840-4.
23. Scordamaglia A, Ciprandi G, Ruffoni S, et al. Theophylline and the immune response: in vitro and in vivo effects. Clin Immunol Immunopathol 1988;48:238-46.
24. Lagente V, Pruniaux MP, Junien JL, Moodley I. Modulation of cytokine-induced eosinophil infiltration by phosphodiesterase inhibitors. Am J Respir Crit Care Med 1995;151:1720-4.
25. Kraft M, Torvik JA, Trudeau JB, Wenzel SE, Martin RJ. Theophylline: potential antiinflammatory effects in nocturnal asthma. J Allergy Clin Immunol (in press).
26. Crescioli S, De Marzo N, Boschetto P, et al. Theophylline inhibits late asthmatic reactions induced by toluene diisocyanate in sensitised subjects. Eur J Pharmacol 1992;228:45-50.
27. Holgate ST, Mann JS, Cushley MJ. Adenosine as a bronchoconstrictor mediator in asthma and its antagonism by methylxanthines. J Allergy Clin Immunol 1984;74:302-6.
28. Simons FE, Luciuk GH, Simons KJ. Sustained-release theophylline for treatment of asthma in preschool children. Am J Dis Child 1982;136:790-3.
29. Neijens HJ, Duiverman EJ, Graatsma BH, Kerrebijn KF. Clinical and bronchodilating efficacy of controlled-release theophylline as a function of its serum concentrations in preschool children. J Pediatr 1985;107:811-5.
30. Rabe KF, Morton BE, Dent G, Coleman RA, Magnussen H. Methylxanthine phosphodiesterase inhibitors block allergen-induced bronchoconstriction of human airways in-vilro. AmJ Respir Crit Care Med 1995;151: Suppl:A388. abstract.
31. Howell RE. Multiple mechanisms of xanthine actions on airway reactivity. J Pharmacol Exp Ther 1990;255:1008-14.
32. Welton AF, Simko BA. Regulatory role of adenosine in antigen-induced histamine release from the lung tissue of actively sensitized guinea pigs. Biochem Pharmacol 1980;29:1085-92.
33. Murciano D, Aubier M, Lecocguic Y, Pariente R. Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. N Engl J Med 1984;311:349-53.
34. Cotromanes E, Gerrity TR, Garrard CS, et al. Aerosol penetration and mucociliary transport in the healthy human lung: effect of low serum the-ophylline levels. Chest 1985;88:194-200.
35. Easton PA, Anthonisen NR. Ventilatory response to sustained hypoxia after pretreatment with aminophylline. J Appl Physiol 1988;64:1445-50.
36. Erjefalt I, Persson CG. Anti-asthma drugs attenuate inflammatory leakage of plasma into airway lumen. Acta Physiol Scand 1986;128:653-4.
37. Rabe KF, Tenor H, Dent G, Nakashima M, Schudt C, Magnussen H. The-ophylline relaxes human airways and pulmonary arteries in vitro through phosphodiesterase inhibition. Am Rev Respir Dis 1993;147:Suppl:A184. abstract.
38. Howell LL, Morse WH, Spealman RD. Respiratory effects of xanthines and adenosine analogs in rhesus monkeys. J Pharmacol Exp Ther 1990; 254:786-91.
39. Howell RE, Muehsam WT, Kinnier WJ. Mechanism for the emetic side effect of xanthine bronchodilators. Life Sci 1990;46:563-8.
40. Bowton DL, Haddon WS, Prough DS, Adair N, Alford PT, Stump DA. Theophylline effect on the cerebral blood flow response to hypoxemia. Chest 1988;94:371-5.
41. 2-adrenergics and steroids are provided. Arch Intern Med 1993;153:1784-8.
42. Self TH, Abou-Shala N, Burns R, et al. Inhaled albuterol and oral prednisone therapy in hospitalized adult asthmatics: does aminophylline add any benefit? Chest 1990;98:1317-21.
43. Huang D, O'Brien RG, Harman E, et al. Does aminophylline benefit adults admitted to the hospital for an acute exacerbation of asthma? Ann Intern Med 1993;119:1155-60.
44. Carter E, Cruz M, Chesrown S, Shieh G, Reilly K, Hendeles L. Efficacy of intravenously administered theophylline in children hospitalized with severe asthma. J Pediatr 1993;122:470-6.
45. DiGiulio GA, Kercsmar CM, Krug SE, Alpert SE, Marx CM. Hospital treatment of asthma: lack of benefit from theophylline given in addition to nebulized albuterol and intravenously administered corticosteroid. J Pediatr 1993;122:464-9.
46. Shapiro GG, Konig P. Cromolyn sodium: a review. Pharmacotherapy 1985;5:156-70.
47. Patel KR, Wall RT. Dose-duration effect of sodium cromoglycate aerosol in exercise-induced asthma. Eur J Respir Dis 1986;69:256-60.
48. Patel KR, Tullett WM, Neale MG, Wall RT, Tan KM. Plasma concentrations of sodium cromoglycate given by nebulisation and metered dose inhalers in patients with exercise-induced asthma: relationship to protective effect. Br J Clin Pharmacol 1986;21:231-3.
49. Heins M, Kurtin L, Oellerich M, Maes R, Sybrecht GW. Nocturnal asthma: slow-release terbutaline versus slow-release theophylline therapy. Eur Respir J 1988;1:306-10.
50. Weinberger M. Salmeterol for the treatment of asthma. Ann Allergy Asthma Immunol 1995;75:209-11.
51. Fjellbirkeland L, Gulsvik A, Palmer JB. The efficacy and tolerability of inhaled salmeterol and individually dose-titrated, sustained-release the-ophylline in patients with reversible airways disease. Respir Med 1994;88: 599-607.
52. 2-adrenoreceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1992;327:1198-203.
53. Ramage L, Lipworth BJ, Ingram CG, Cree IA, Dhillon DP. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med 1994;88:363-8.
54. Giannini D, Carletti A, Dente FL, et al. Tolerance to salmeterol in allergen induced bronchoconstriction. Am J Respir Crit Care Med 1995;151:Suppl: A39. abstract.
55. Bierman CW, Shapiro GG, Pierson WE, Dorsett CS. Acute and chronic theophylline therapy in exercise-induced bronchospasm. Pediatrics 1977; 60:845-9.
56. Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993;92:64-77.
57. Matthys H, Muller S, Herceg R. Theophylline vs. budesonide in the treatment of mild-to-moderate bronchial asthma. Respiration 1994;61:241-8.
58. Toogood JH, Jennings B, Lefcoe NM. A clinical trial of combined cromolyn/beclomethasone treatment for chronic asthma. J Allergy Clin Immunol 1981;67:317-24.
59. Miller EJ, Milner AD. Betamethasone 17 valerate aerosol and disodium chromoglycate in severe childhood asthma. Br J Dis Chest 1975;69:103-6.
60. Dawood AG, Hendry AT, Walker SR. The combined use of betamethasone valerate and sodium cromoglycate in the treatment of asthma. Clin Allergy 1977;7:161-5.
61. Svendsen UG, Jorgensen H. Inhaled nedocromil sodium as additional treatment to high dose inhaled corticosteroids in the management of bronchial asthma. Eur Respir J 1991;4:992-9.
62. O'Hickey SP, Rees PJ. High-dose nedocromil sodium as an addition to inhaled corticosteroids in the treatment of asthma. Respir Med 1994;88:499-502.
63. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994;344:219-24.
64. Milavetz G, Vaughan LM, Weinberger MM, Hendeles L. Evaluation of a scheme for establishing and maintaining dosage of theophylline in ambulatory patients with chronic asthma. J Pediatr 1986;109:351-4.
65. Hendeles L, Weinberger M, Szefler S, Ellis E. Safety and efficacy of the-ophylline in children with asthma. J Pediatr 1992;120:177-83.
66. Hendeles L, Jenkins J, Temple R. Revised FDA labeling guideline for the-ophylline oral dosage forms. Pharmacotherapy 1995;15:409-27.
67. Hendeles L, Bighley L. Richardson RH, Hepler CD, Carmichael J. Frequent toxicity from IV aminophylline infusions in critically ill patients. Drug Intell Clin Pharm 1977;11:12-8.
68. Sessler CN. Theophylline toxicity: clinical features of 116 consecutive cases. Am J Med 1990;88:567-76.
69. Shannon M. Predictors of major toxicity after theophylline overdose. Ann Intern Med 1993;119:1161-7.
70. Hendeles L, Massanari M, Weinberger M. Theophylline. In: Evans WE, Schentag JJ, Jusko WJ, eds. Applied pharmacokinetics: principles of therapeutic drug monitoring. 2nd ed. Spokane, Wash.: Applied Therapeutics, 1986:1105-88.
71. Weinberger M, Hendeles L. Theophylline. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: principles and practice. 4th ed. Vol. 1. St. Louis: Mosby-Year Book. 1993:816-55.
72. Sarkar MA, Hunt C, Guzelian PS, Karnes HT. Characterization of human liver cytochromes P-450 involved in theophylline metabolism. Drug Metab Dispos Biol Fate Chem 1992;20:31-7.
73. Milavetz G, Vaughan LM, Weinberger MM. Stability of theophylline elimination rate. Clin Pharmacol Ther 1987;41:388-91.
74. Sarrazin E, Hendeles L, Weinberger M, Muir K. Riegelman S. Dose-dependent kinetics for theophylline: observations among ambulatory asthmatic children. J Pediatr 1980;97:825-8.
75. Chang KC, Bell TD, Lauer BA, Chai H. Altered theophylline pharmacokinetics during acute respiratory viral illness. Lancet 1978;1:1132-3.
76. Kraemer MJ, Furukawa CT, Koup JR, Shapiro GG, Pierson WE, Bierman CW. Altered theophylline clearance during an influenza B outbreak. Pediatrics 1982;69:476-80.
77. Matthay RA, Matthay MA, Weinberger MM. Grand mal seizure induced by oral theophylline. Thorax 1976;31:470-1.
78. Muslow HA, Bernard L, Brown RD, et al. Lack of effect of respiratory syncytial virus infection on theophylline disposition in children. J Pediatr 1992;121:466-71.
79. Bachmann K, Schwartz J, Martin M, Jauregui L. Theophylline clearance during and after mild upper respiratory infection. Ther Drug Monit 1987; 9:279-82.
80. Matsunga SK, Plezia PM, Karol MD, Katz MD, Camilli AE, Benowitz NL. Effects of passive smoking on theophylline clearance. Clin Pharmacol Ther 1989;46:399-407.
81. Billing B, Dahlqvist R, Garle M, Hornblad Y, Ripe E. Separate and combined use of terbutaline and theophylline in asthmatics: effects related to plasma levels. Eur J Respir Dis 1982;63:399-409.
82. Stirt JA, Berger JM, Roe SD, Ricker SM, Sullivan SF. Halothane-induced cardiac arrhythmias following administration of aminophylline in experimental animals. Anesth Analg 1981;60:517-20.
83. Hirshman CA, Krieger W, Littlejohn G, Lee R, Julien R. Ketamine-aminophylline-induced decrease in seizure threshold. Anesthesiology 1982; 56:464-7.
84. Bonfiglio MF, Dasta JF. Clinical significance of the benzodiazepine-theophylline interaction. Pharmacotherapy 1991;11:85-7.
85. Doll DC, Rosenberg H. Antagonism of neuromuscular blockage by the-ophylline. Anesth Analg 1979;58:139-40.
86. Schiff GD, Hegde HK, LaCloche, Hryhorczuk DO. Inpatient theophylline toxicity: preventable factors. Ann Intern Med 1991;114:748-53.
87. Derby LE, Jick SS, Langlois JC, Johnson EL, Jick H. Hospital admission for xanthine toxicity. Pharmacotherapy 1990;10:112-4.
88. Joad JP, Ahrens RC, Lindgren SD, Weinberger MM. Extrapulmonary effects of maintenance therapy with theophylline and inhaled albuterol in patients with chronic asthma. J Allergy Clin Immunol 1986;78:1147-53.
89. Stein MA, Lerner CA. Behavioral and cognitive effect of theophylline: a dose-response study. Ann Allergy 1993;70:135-40.
90. Lindgren S, Lokshin B, Stromquist A, et al. Does asthma or treatment with theophylline limit children's academic performance? N Engl J Med 1992; 327:926-30.
91. Bender B, Milgrom H. Theophylline-induced behavior change in children: an objective evaluation of parents' perception. JAMA 1992;267:2621-4.
92. Avital A, Steljes DG, Pasterkamp H, Kryger M, Sanchez I, Chernick V. Sleep quality in children with asthma treated with theophylline or cromolyn sodium. J Pediatr 1991;119:979-84.
93. Nassif E, Weinberger M, Sherman B, Brown K. Extrapulmonary effects of maintenance corticosteroid therapy with alternate-day prednisone and inhaled beclomethasone in children with chronic asthma. J Allergy Clin Immunol 1987;80:518-29.
94. Molema J, van Herwaarden CL, Folgering HT. Effects of long-term treatment with inhaled cromoglycate and budesonide on bronchial hyperresponsiveness in patients with allergic asthma. Eur Respir J 1989;2:308-16.
95. Groot CA, Lammers JW, Molema J, Festen J, van Herwaarden CL. Effect of inhaled beclomethasone and nedocromil sodium on bronchial hyperresponsiveness to histamine and distilled water. Eur Respir J 1992;5:1075-82.
96. Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994;154:1349-52.
97. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995;332: 868-75.
98. Idem. Cyclic nucleotides and phosphodiesterases and airway function. Eur Respir J 1995;8:457-62.
99. 4-receptor antagonist, in subjects with bronchial asthma. Am J Respir Crit Care Med 1994;150:618-23.
100. Israel E, Rubin P, Kemp JP, et al. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann Intern Med 1993;119:1059-66.